Quantum Notifications.
Delivered to Your Phone.
Advancing Science, Saving Lives
🧪 Innovative neuro disorders therapies to millions of patients in need
⚡ Stay informed with our lastest updates
🔒 Free forever. Unsubscribe anytime.
Subscribe Now
By checking this box and submitting this form, you consent to receive informational SMS messages from Quantum BioPharma, including financial news and market analysis. Message frequency may vary. Message and data rates may apply. Reply STOP to opt out and HELP for help. Consent is not a condition of purchase. You may be required to reply YES to confirm your subscription.
I agree with the
Privacy Policy
and
Terms & Conditions
Latest Press Releases
Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital
Promising Early Data Strengthens Potential of Novel PET Technology to Advance Development of Lucid-MS for Multiple Sclerosis...
Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026
Investigational New Drug (IND) Application Filed to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant
Quantum BioPharma, a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces that Unbuzzd Wellness Inc...